Ascendis Pharma A (ASND) Change in Cash (2014 - 2026)
Ascendis Pharma A (ASND) posted Change in Cash of -$60.1 million for Q1 2026, down 165.72% sequentially from $91.4 million in Q4 2025, and down 72.83% YoY from -$221.1 million in Q1 2025.
Ascendis Pharma A (ASND) Change in Cash (2014 - 2026) Analysis & Trends
Ascendis Pharma A has reported Change in Cash for 13 years, with the latest figure at -$60.1 million in Q1 2026.
- Quarterly Change in Cash fell 72.83% year-over-year to -$60.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $73.9 million (down 66.77% YoY) and the FY2025 annual result came in at $95.1 million, down 57.98% from the prior year.
- Change in Cash eased to -$60.1 million in Q1 2026 per ASND's latest filing, from $91.4 million in the prior quarter.
- Over five years, Change in Cash peaked at $848.1 million in Q1 2022 and troughed at -$118.1 million in Q2 2023.
- A 5-year average of $70.3 million and a median of -$20.0 million in 2025 frame the typical range for Change in Cash.
- The widest YoY moves for Change in Cash: up 816.62% in 2024, down 222.3% in 2024.
- Over 5 years, Change in Cash stood at -$64.6 million in 2022, then surged by 168.87% to $44.5 million in 2023, then surged by 816.62% to $407.7 million in 2024, then sank by 77.58% to $91.4 million in 2025, then slumped by 165.72% to -$60.1 million in 2026.
- According to Business Quant data, Change in Cash over the past three periods registered -$60.1 million, $91.4 million, and $47.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 427.25 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.97 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.94 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.42 Mn |
| 10 | Ascendis Pharma A | 15.40 Bn | 14.73 Bn | 268.20 Mn | -60.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -60.07 Mn |
| Dec 31, 2025 | 91.41 Mn |
| Sep 30, 2025 | 47.88 Mn |
| Jun 30, 2025 | -5.32 Mn |
| Mar 31, 2025 | -34.75 Mn |
| Sep 30, 2024 | 407.70 Mn |
| Jun 30, 2024 | -68.01 Mn |
| Mar 31, 2024 | -82.57 Mn |
| Sep 30, 2023 | 44.48 Mn |
| Jun 30, 2023 | -118.13 Mn |
| Mar 31, 2023 | 67.51 Mn |
| Sep 30, 2022 | -64.59 Mn |
| Jun 30, 2022 | -88.84 Mn |
| Mar 31, 2022 | 848.09 Mn |
| Sep 30, 2021 | 363.69 Mn |
| Jun 30, 2021 | -133.08 Mn |
| Mar 31, 2021 | 597.14 Mn |
| Sep 30, 2020 | 1.31 Bn |
| Jun 30, 2020 | -985.36 Mn |
| Mar 31, 2020 | 589.92 Mn |